Hospitalacquired PowerPoint PPT Presentations

Incidence of Gram-negative Bacteria in Nosocomial Infections. Incidence ... Causes nosocomial pneumonia, skin and wound infections, bacteremia, meningitis ...

Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada) ... Pulmonary radiography. No infiltrate 0. Diffuse or patchy infiltrate 1 ...

The newest report on the global cardiology electrodes market highlights the key trends, investment opportunities, as well as challenges in this market. Key insights include CAGR, year over year growth rate, geographical distribution, as well as market segmentation by type. This report on cardiology electrodes also includes the names of the leading vendors and their latest products. The report is designed to enable industry heads, stakeholders, and investors to make intelligent business decisions.

Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being multidrug resistant, these organisms are immune to the conventional antibiotics hence difficult to treat.

The development of technologically advanced products is positively impacting the hospital-acquired infection (HAI) diagnostics domain. Advancements in technology have revolutionized the HAI diagnostics domain by enabling the development of products that offer reliable results in less time. For instance, in 2017, Roche Diagnostics launched the cobas Liat PCR system with four assays with the ability to conduct a real-time PCR nucleic acid test for Clostridium difficile detection in 20 minutes.

The ‘Global and Chinese Hospital-acquired Pneumonia (HAP) Drugs Industry, 2013–2023 Market Research Report’ is a professional and in-depth study on the current state of the global Hospital-acquired Pneumonia (HAP) Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hospital-acquired Pneumonia (HAP) Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Hospital-acquired infections can be extremely distressing for patients who are already ailing through an existing condition.

Pharmaion Consultants offers latest market research report “United States Hospital-acquired Infections Prevention Market Opportunities, 2010 - 2020” that studies the market size and share of various segments and sub-segments of the hospital-acquired infections prevention market in the United States during the period 2010 - 2020.